Company intelligence / Profile preview

St. Teresa Medical

Eagan / Saint Paul area, Minnesota, United Statesstteresamedical.com ↗

Ownership: Private
Employees: ~7
Development stage: Other

Overview

St. Teresa Medical develops proprietary hemostatic medical devices using nanotechnology platforms such as FibriSEAL, FASTCLOT®, and SurgiClot to control surgical and traumatic bleeding by accelerating the clotting cascade with embedded human-derived clotting proteins. The company’s products are designed for rapid, robust clot formation in surgery or trauma settings but do not appear to be commercially launched yet. No published pivotal clinical trial results were found.

Therapeutic areas: Hematology
Modalities: DeviceBiologic (fibrinogen and thrombin-based)Nanotechnology-based medical device
Industry: Surgical Medical Devices

Partnerships

Lee Biosolutions (component manufacturing)Virginia Commonwealth UniversityHenry Jackson Foundation for the Advancement of Military Medicine

Beyond the preview

Go deeper on St. Teresa Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on St. Teresa Medical.